Source: http://www.google.com/patents/US7976836?ie=ISO-8859-1
Timestamp: 2014-04-19 02:47:58
Document Index: 152178857

Matched Legal Cases: ['Application No. 10183435', 'Application No. 10183252', 'Application No. 10182195', 'Application No. 10182243', 'Application No. 10182362', 'Application No. 10182485', 'Application No. 10183301', 'Application No. 10182433', 'Application No. 10183378', 'Application No. 10182303']

Patent US7976836 - Treatment of stroke using placental stem cells - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inAdvanced Patent SearchPatentsThe present invention provides a method of extracting and recovering embryonic-like stem cells, including, but not limited to pluripotent or multipotent stem cells, from an exsanguinated human placenta. A placenta is treated to remove residual umbilical cord blood by perfusing an exsanguinated placenta,...http://www.google.com/patents/US7976836?utm_source=gb-gplus-sharePatent US7976836 - Treatment of stroke using placental stem cellsAdvanced Patent SearchPublication numberUS7976836 B2Publication typeGrantApplication numberUS 12/341,961Publication dateJul 12, 2011Filing dateDec 22, 2008Priority dateDec 6, 2000Also published asCA2430989A1, CA2678490A1, EP1349918A1, EP1349918A4, EP2206772A2, EP2206772A3, EP2305795A1, EP2322601A1, US7045148, US7638141, US8293223, US8545833, US8580563, US20020123141, US20050272148, US20090053805, US20090142831, US20100120015, US20110217271, US20110217272, US20110223141, US20120020936, US20120058089, WO2002046373A1, WO2002046373A8, WO2002046373A9Publication number12341961, 341961, US 7976836 B2, US 7976836B2, US-B2-7976836, US7976836 B2, US7976836B2InventorsRobert J. HaririOriginal AssigneeAnthrogenesis CorporationExport CitationBiBTeX, EndNote, RefManPatent Citations (103), Non-Patent Citations (192), Referenced by (9), Classifications (53), Legal Events (1) External Links: USPTO, USPTO Assignment, EspacenetTreatment of stroke using placental stem cellsUS 7976836 B2Abstract The present invention provides a method of extracting and recovering embryonic-like stem cells, including, but not limited to pluripotent or multipotent stem cells, from an exsanguinated human placenta. A placenta is treated to remove residual umbilical cord blood by perfusing an exsanguinated placenta, preferably with an anticoagulant solution, to flush out residual cells. The residual cells and perfusion liquid from the exsanguinated placenta are collected, and the embryonic-like stem cells are separated from the residual cells and perfusion liquid. The invention also provides a method of utilizing the isolated and perfused placenta as a bioreactor in which to propagate endogenous cells, including, but not limited to, embryonic-like stem cells. The invention also provides methods for propagation of exogenous cells in a placental bioreactor and collecting the propagated exogenous cells and bioactive molecules therefrom.
Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS3862002Jul 3, 1967Jan 21, 1975Sanfar Lab IncProduction of physiologically active placental substancesUS4829000May 27, 1986May 9, 1989The United States Of America As Represented By The Secretary Of The Department Of Health And Human ServicesReconstituted basement membrane complex with biological activityUS5004681Nov 12, 1987Apr 2, 1991Biocyte CorporationPreservation of fetal and neonatal hematopoietic stem and progenitor cells of the bloodUS5192553Nov 10, 1988Mar 9, 1993Biocyte CorporationIsolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic useUS5197985Nov 16, 1990Mar 30, 1993Caplan Arnold IMethod for enhancing the implantation and differentiation of marrow-derived mesenchymal cellsUS5226914Nov 16, 1990Jul 13, 1993Caplan Arnold IMethod for treating connective tissue disordersUS5272071Dec 21, 1990Dec 21, 1993Applied Research Systems Ars Holding N.V.Method for the modification of the expression characteristics of an endogenous gene of a given cell lineUS5356373Nov 15, 1991Oct 18, 1994Miles Inc.Method and apparatus for autologous transfusions in premature infantsUS5372581Jul 21, 1993Dec 13, 1994Minneapolis Children's Services CorporationMethod and apparatus for placental blood collectionUS5415665Jan 26, 1993May 16, 1995Utah Medical Products, Inc.Umbilical cord clamping, cutting, and blood collecting device and methodUS5437994Dec 10, 1993Aug 1, 1995Regents Of The University Of MichiganMethod for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cellsUS5460964Mar 17, 1993Oct 24, 1995Regents Of The University Of MinnesotaMethod for culturing hematopoietic cellsUS5464764Feb 4, 1993Nov 7, 1995University Of Utah Research FoundationPositive-negative selection methods and vectorsUS5486359Feb 8, 1994Jan 23, 1996Osiris Therapeutics, Inc.Human mesenchymal stem cellsUS5487992Jun 28, 1993Jan 30, 1996University Of Utah Research FoundationCells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making sameUS5516532Aug 5, 1994May 14, 1996Children's Medical Center CorporationInjectable non-immunogenic cartilage and bone preparationUS5591625Nov 24, 1993Jan 7, 1997Case Western Reserve UniversityTransduced mesenchymal stem cellsUS5605822Dec 1, 1994Feb 25, 1997The Regents Of The University Of MichiganMethods, compositions and devices for growing human hematopoietic cellsUS5627059Jun 5, 1995May 6, 1997University Of UtahCells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making sameUS5635386Nov 2, 1994Jun 3, 1997The Regents Of The University Of MichiganMethods for regulating the specific lineages of cells produced in a human hematopoietic cell cultureUS5635387Apr 3, 1995Jun 3, 1997Cellpro, Inc.Methods and device for culturing human hematopoietic cells and their precursorsUS5643741Jun 6, 1995Jul 1, 1997Systemix, Inc.Identification and isolation of human hematopoietic stem cellsUS5646043Mar 10, 1995Jul 8, 1997Regents Of The University Of MichiganMethods for the ex vivo replication of human stem cells and/or expansion of human progenitor cellsUS5654186Feb 26, 1993Aug 5, 1997The Picower Institute For Medical ResearchBlood-borne mesenchymal cellsUS5654381Jun 16, 1995Aug 5, 1997Massachusetts Institute Of TechnologyFunctionalized polyester graft copolymersUS5665557Nov 14, 1994Sep 9, 1997Systemix, Inc.Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereofUS5668104Mar 31, 1993Sep 16, 1997Toray Industries, Inc.Hematopoietic stem cell growth-promoting compositions containing a fibroblast-derived fragment of fibronectin and a growth factor, and methods employing them in vitro or in vivoUS5670147Dec 1, 1994Sep 23, 1997Regents Of The University Of MichiganCompositions containing cultured mitotic human stem cellsUS5670351Dec 30, 1994Sep 23, 1997The Regents Of The University Of MichiganMethods and compositions for the ex vivo replication of human hematopoietic stem cellsUS5672346Jun 15, 1993Sep 30, 1997Indiana University FoundationHuman stem cell compositions and methodsUS5709854Apr 30, 1993Jan 20, 1998Massachusetts Institute Of TechnologyTissue formation by injecting a cell-polymeric solution that gels in vivoUS5716616Mar 28, 1995Feb 10, 1998Thomas Jefferson UniversityIsolated stromal cells for treating diseases, disorders or conditions characterized by bone defectsUS5716794Mar 29, 1996Feb 10, 1998Xybernaut CorporationCeliac antigenUS5716827Jun 6, 1995Feb 10, 1998Systemix, Inc.Human hematopoietic stem cellUS5733541Apr 21, 1995Mar 31, 1998The Regent Of The University Of MichiganHematopoietic cells: compositions and methodsUS5733542Jan 24, 1995Mar 31, 1998Haynesworth; Stephen E.Enhancing bone marrow engraftment using MSCSUS5736396Jan 24, 1995Apr 7, 1998Case Western Reserve UniversityLineage-directed induction of human mesenchymal stem cell differentiationUS5744361Jun 6, 1995Apr 28, 1998Indiana UniversityExpansion of human hematopoietic progenitor cells in a liquid mediumUS5750397Jun 6, 1995May 12, 1998Systemix, Inc.Human hematopoietic stem cellUS5763197Jun 25, 1991Jun 9, 1998Systemix, Inc.Human hematopoietic stem cellUS5763266Mar 4, 1993Jun 9, 1998The Regents Of The University Of MichiganMethods, compositions and devices for maintaining and growing human stem and/or hematopoietics cellsUS5807686Jun 6, 1995Sep 15, 1998Regents Of University Of MinnesotaPluripotential quiescent stem cell populationUS5811094Apr 11, 1995Sep 22, 1998Osiris Therapeutics, Inc.Connective tissue regeneration using human mesenchymal stem cell preparationsUS5827735May 20, 1996Oct 27, 1998Morphogen Pharmaceuticals, Inc.Pluripotent mesenchymal stem cells and methods of use thereofUS5827740Jul 30, 1996Oct 27, 1998Osiris Therapeutics, Inc.Adipogenic differentiation of human mesenchymal stem cellsUS5827742Sep 1, 1994Oct 27, 1998Beth Israel Deaconess Medical Center, Inc.Method of selecting pluripotent hematopioetic progenitor cellsUS5837539Jun 2, 1995Nov 17, 1998Osiris Therapeutics, Inc.Monoclonal antibodies for human mesenchymal stem cellsUS5849553Jun 7, 1995Dec 15, 1998California Institute Of TechnologyMammalian multipotent neural stem cellsUS5851984Aug 16, 1996Dec 22, 1998Genentech, Inc.Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptidesUS5855619Sep 30, 1996Jan 5, 1999Case Western Reserve UniversityBiomatrix for soft tissue regenerationUS5858782Nov 13, 1995Jan 12, 1999Regents Of The University Of MichiganFunctional human hematopoietic cellsUS5861315Oct 16, 1996Jan 19, 1999Amgen Inc.Use of stem cell factor and soluble interleukin-6 receptor for the ex vivo expansion of hematopoietic multipotential cellsUS5866414Sep 19, 1995Feb 2, 1999Badylak; Stephen F.Submucosa gel as a growth substrate for cellsUS5874301Dec 11, 1995Feb 23, 1999National Jewish Center For Immunology And Respiratory MedicineEmbryonic cell populations and methods to isolate such populationsUS5877299Jun 16, 1995Mar 2, 1999Stemcell Technologies Inc.Methods for preparing enriched human hematopoietic cell preparationsUS5879318Aug 18, 1997Mar 9, 1999Npbi International B.V.Method of and closed system for collecting and processing umbilical cord bloodUS5879940May 23, 1997Mar 9, 1999Fred Hutchinson Cancer Research CenterHuman marrow stromal cell lines which sustain hematopoiesesUS5905041Jun 28, 1995May 18, 1999Boehringer Ingelheim International GmbhProcess for preparing and cultivating hematopoietic progenitor cellsUS5906934Mar 14, 1995May 25, 1999Morphogen Pharmaceuticals, Inc.Mesenchymal stem cells for cartilage repairUS5908782Jun 5, 1995Jun 1, 1999Osiris Therapeutics, Inc.Chemically defined medium for human mesenchymal stem cellsUS5908784Nov 15, 1996Jun 1, 1999Case Western Reserve UniversityIn vitro chondrogenic induction of human mesenchymal stem cellsUS5914108Jun 6, 1995Jun 22, 1999Systemix, Inc.Human hematopoietic stem cellUS5914268Nov 21, 1994Jun 22, 1999National Jewish Center For Immunology & Respiratory MedicineEmbryonic cell populations and methods to isolate such populationsUS5916202Aug 30, 1996Jun 29, 1999Haswell; John N.Umbilical cord blood collectionUS5919176Oct 30, 1996Jul 6, 1999Children's Hospital Medical Center Of Northern CaliforniaApparatus and method for collecting blood from an umbilical cordUS5919702Oct 23, 1996Jul 6, 1999Advanced Tissue Science, Inc.Production of cartilage tissue using cells isolated from Wharton's jellyUS5922597Nov 13, 1996Jul 13, 1999Regents Of The University Of MinnesotaEx vivo culture of stem cellsUS5925567Oct 6, 1997Jul 20, 1999T. Breeders, Inc.Selective expansion of target cell populationsUS5928214Aug 3, 1998Jul 27, 1999New York Blood Center, Inc.High concentration white cells, a method for agglomeration of the high concentration and a bag set for use in conjunction therewithUS5928947Jun 7, 1995Jul 27, 1999California Institute Of TechnologyMammalian multipotent neural stem cellsUS5942225Jul 23, 1997Aug 24, 1999Case Western Reserve UniversityLineage-directed induction of human mesenchymal stem cell differentiationUS5942496Sep 30, 1994Aug 24, 1999The Regent Of The University Of MichiganMethods and compositions for multiple gene transfer into bone cellsUS5958767Aug 14, 1998Sep 28, 1999The Children's Medical Center Corp.Engraftable human neural stem cellsUS5962325Sep 18, 1998Oct 5, 1999Advanced Tissue Sciences, Inc.Three-dimensional stromal tissue culturesUS5968829Sep 5, 1997Oct 19, 1999Cytotherapeutics, Inc.Human CNS neural stem cellsUS5969105Oct 21, 1997Oct 19, 1999Feng; YiqingStem cell factor receptor agonistsUS5993429May 14, 1997Nov 30, 1999Childen's Hospital Medical Center Of Northern CaliforniaApparatus and method for collecting blood from an umbilical cordUS5997860Nov 15, 1995Dec 7, 1999G. D. Searle & Co.Ex-vivo expansion of stem cells using combinations of interleukin-3 (IL-3) variants and other cytokinesUS6001654Apr 25, 1997Dec 14, 1999California Institute Of TechnologyMethods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factorsUS6010696Mar 25, 1998Jan 4, 2000Osiris Therapeutics, Inc.Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cellsUS6011000Jun 6, 1995Jan 4, 2000Perrine; Susan P.Compositions for the treatment of blood disordersUS6020469Apr 15, 1999Feb 1, 2000Amgen Inc.Stem cell factor formulations and methodsUS6022540Aug 28, 1998Feb 8, 2000Osiris Therapeutics, Inc.Ligands that modulate differentiation of mesenchymal stem cellsUS6022743Mar 8, 1999Feb 8, 2000Advanced Tissue Sciences, Inc.Three-dimensional culture of pancreatic parenchymal cells cultured living stromal tissue prepared in vitroUS6022848Sep 30, 1994Feb 8, 2000Pro-Neuron, Inc.Inhibitor of stem cell proliferation and uses thereofUS6030836Jun 8, 1999Feb 29, 2000Osiris Therapeutics, Inc.Vitro maintenance of hematopoietic stem cellsUS6057123Dec 23, 1992May 2, 2000British Biotech Pharmaceuticals LimitedStem cell inhibiting proteinsUS6059968Jan 20, 1998May 9, 2000Baxter International Inc.Systems for processing and storing placenta/umbilical cord bloodUS6077708Sep 24, 1998Jun 20, 2000Collins; Paul C.Method of determining progenitor cell content of a hematopoietic cell cultureUS6087113May 19, 1998Jul 11, 2000Case Western Reserve UniversityMonoclonal antibodies for human mesenchymal stem cellsUS6093531Jun 19, 1998Jul 25, 2000Neurospheres Holdings Ltd.Generation of hematopoietic cells from multipotent neural stem cellsUS6110739Feb 22, 1999Aug 29, 2000National Jewish Medical And Research CenterMethod to produce novel embryonic cell populationsUS6127135May 27, 1998Oct 3, 2000Hill; Beth LouiseMethods of obtaining compositions enriched for hematopoietic stem cells, antibodies for use therein, compositions derived therefrom and methods of use thereofUS6146888Apr 21, 1994Nov 14, 2000The University Of EdinburghMethod of enriching for mammalian stem cellsUS6174333Dec 29, 1998Jan 16, 2001Osiris Therapeutics, Inc.Biomatrix for soft tissue regeneration using mesenchymal stem cellsUS6179819Sep 9, 1999Jan 30, 2001John N. HaswellUmbilical cord blood collectionUS6184035Nov 18, 1998Feb 6, 2001California Institute Of TechnologyMethods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cellsUS6190368May 12, 1999Feb 20, 2001Children's Hospital Medical Center Of Northern CaliforniaApparatus and method for collecting blood from an umbilical cordUS6214369May 6, 1999Apr 10, 2001Morphogen Pharmaceuticals, Inc.Mesenchymal stem cells for cartilage repairUS6528245 *May 7, 1999Mar 4, 2003University Of South FloridaBone marrow cells as a source of neurons for brain and spinal cord repairUS7311905 *Feb 13, 2003Dec 25, 2007Anthrogenesis CorporationEmbryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cellsUS7468276 *Jun 22, 2004Dec 23, 2008Anthrogenesis CorporationPlacental stem cellsUS7700090 *Dec 28, 2006Apr 20, 2010Anthrogenesis CorporationCo-culture of placental stem cells and stem cells from a second source* Cited by examinerNon-Patent CitationsReference1Abbott, 2003, ABCG2 (BCRP)expression in normal and malignant hematopoietic cells, Hematol Oncol 21:115-130.2Abe, "Therapeutic Potential of Neurotrophic Factors and Neural Stem Cells Against lschemic Brain Injury," Journal of Cerebral Blood Flow and Metabolism, Raven Press, Ltd., New York, 20(10): 1393-1408 (2000).3Abkowitz, 2002, Can human hematopoietic stem cells become skin, gut, or liver cells? N Engl J Med. 346(10):770-2.4Addison et al., "Metabolism of Prednisolone by the Isolated Perfused Human Placental Lobule", J. Ster. Biochem Mol. Biol., vol. 39 No. 1, pp. 83-90 (1991).5Advisory Action dated Aug. 17, 2009 in U.S. Appl. No. 10/721,444.6Advisory Action dated Feb. 6, 2006 in U.S. Appl. No. 10/721,144.7Advisory Action dated Jul. 12, 2004 in U.S. Appl. No. 10/076,180.8Advisory Action dated Jun. 6, 2006 in U.S. Appl. No. 10/779,369.9Advisory Action dated Oct. 7, 2009 in U.S. Appl. No. 10/721,144.10Ballin, et al., "Autologous Umbilical Cord Blood Transfusion," Arch. Dis. Child Fetal Neonatal. Ed. 73(3):F181-F183 (1995).11 *Barlow et al. Stem Cell Dev 2008;17:1095-1108.12Barry, 1994, "Where do all the placentas go?" Canadian Journal of Infection Control 9(1):8-10.13Belvedere et al., 2000, "Increased blood volume and CD34(+)CD36(-) progenitor cell recovery using a novel umbilical cord blood collection system," Stem Cells 18(4):245-251.14Belvedere et al., 2000, "Increased blood volume and CD34(+)CD36(−) progenitor cell recovery using a novel umbilical cord blood collection system," Stem Cells 18(4):245-251.15Bertolini et al., 1994, Retrovirus-mediated transfer of the multidrug resistance gene into human haemopoietic progenitor cells. Haemolotol 88:318-324.16Caplan, Clin Plast Surg 21(3):429-435 (1994).17CD34, Medline Mesh Database, 2004.18Chen et al. "Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats" Stroke 32:2682-2688 (2001).19Cole et al., 1985, EBV-Hydrudoma techique and its application to human lung cancer. In Monoclonal Antibodies and Cancer Therapy, Alan R. Liss, Inc., 77-96.20Conget et al. "Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells" Journal of Cellular Physiology 181:67-73 (1999).21Contractor et al., 1984, "A comparison of the effects of different perfusion regimens on the structure of the isolated human placental lobule," Cell Tissue Res. 237:609-617.22Cord Blood Stem Cell, Mesh Term Database, 2003.23Cote et al., 1983, Generation of human monoclonal antibodies reactive with cellular antigens. Proc Natl Acad Sci U S A. 80(7):2026-30.24Damjanov et al., 1993, Retinoic acid-induced differentiation of the developmentally plutipotent human germ cell tumor-derived cell line, NCCIT. Lab Invest. 68(2):220-32.25 *Deans et al. Exp Hematol 2000;28: 875-84.26DeLoia et al, 1998, Effects of methotrexate on trophoblast proliferation and local immune responses.Hum Reprod. 13(4):1063-9.27Denison et al. "Cytokine secretion by human fetal membranes, decidua and placenta at term" Human Reproduction 13(12):3560-3565 (1998).28Dorrel, 2000, Expansion of human cord blood CD34+CD38- cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulation cell (SRC) frequency: dissociation of SRC phenotype and function, Blood, 95(1):102-110.29Dorrel, 2000, Expansion of human cord blood CD34+CD38− cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulation cell (SRC) frequency: dissociation of SRC phenotype and function, Blood, 95(1):102-110.30Douay et al, 1995. Characterization of late and early hematopoietic progenitor/stem cell sensitivity to mafosfamide. Bone Marrow Transplant. 15(5):769-75.31Dushnik-Levinson et al. 1995, Embryogenesis in vitro: study of differentiation of embryonic stem cells.Biol Neonate. 67(2):77-83.32Elebalal et al., 2000, "Postpartum umbilical cord blood collection for transplantation: a comparison of three methods," Am. J. of Obstetrics & Gyn. 182(1 Pt 1):227-232.33Emerson, 1996, Ex vivo expansion of hematopoietic precursors, progenitors and stem cells: the next generation of cellular therapeutics, Blood, 87:3072-3088.34Ende, "Pooled umbilical cord blood as a possible universal donor for marrow reconstitution and use in nuclear accidents," Life Sciences 69:1531-1539 (2001).35Erices et al., "Mesenchymal progenitor cells in human umbilical cord blood," Br. J. Haematol. 109(1):235-242 (2000).36Extended European Search Report dated Mar. 11, 2011 for EP Application No. 10183435.6-2401 (specification corresponding to U.S. Patent No. 7,045,148).37Extended European Search Report dated Mar. 22, 2011 for EP Application No. 10183252.5-2401 (specification corresponding to U.S. Patent No. 7,311,904).38Extended European Search Report dated Mar. 25, 2011 for EP Application No. 10182195.7-2401 (specification corresponding to U.S. Patent No. 7,468,276).39Extended European Search Report dated Mar. 25, 2011 for EP Application No. 10182243.5-2401 (specification corresponding to U.S. Patent No. 7,468,276).40Extended European Search Report dated Mar. 25, 2011 for EP Application No. 10182362.3-2401 (specification corresponding to U.S. Patent No. 7,468,276).41Extended European Search Report dated Mar. 25, 2011 for EP Application No. 10182485.2-2401 (specification corresponding to U.S. Patent No. 7,468,276).42Extended European Search Report dated Mar. 25, 2011 for EP Application No. 10183301.0-2401 (specification corresponding to U.S. Patent No. 7,311,904).43Extended European Search Report dated Mar. 28, 2011 for EP Application No. 10182433.2-2401 (specification corresponding to U.S. Patent No. 7,468,276).44Extended European Search Report dated Mar. 3, 2011 for EP Application No. 10183378.8-2401 (specification corresponding to U.S. Patent No. 7,045,148).45Extended European Search Report dated Mar. 30, 2011 for EP Application No. 10182303.7-2401 (specification corresponding to U.S. Patent No. 7,468,276).46Extended Search Report mailed Mar. 25, 2011 in Application No. EP 10182243.5-2401.47Fasouliotis et al., "Human umbilical cord blood banking and transplantation: a state of the art," Eur. J. Obstet. Gynecol. Reprod. Biol. 90(1):13-25 (2000).48Fassas, et al., "Autologous Stem Cell Transplantation in Progressive Multiple Sclerosis�An Interim Analysis of Efficacy," J. Clin, Immunol., 20(1):24-30 (2000).49Final Office Action dated Aug. 4, 2010 in U.S. Appl. No. 11/592,544.50Final Office Action dated Feb. 1, 2011 in U.S. Appl. No. 11/982,291.51Final Office Action dated Feb. 7, 2011 in U.S. Appl. No. 12/030,161.52Final Office Action dated Jan. 28, 2011 in U.S. Appl. No. 11/982,007.53Final Office Action dated May 20, 2010 in U.S. Appl. No. 11/648,804.54Final Office Action dated Nov. 3, 2010 in U.S. Appl. No. 11/982,211.55Final Office Action dated Nov. 3, 2010 in U.S. Appl. No. 12/030,170.56Final Office Action dated Nov. 7, 2005 in U.S. Appl. No. 10/779,369.57Final Office Action dated Oct. 27, 2009 in U.S. Appl. No. 11/648,813.58Final Office Action dated Sep. 14, 2010 in U.S. Appl. No. 10/721,144.59Genbacev et al. 1995,Maternal smoking inhibits early human cytotrophoblast differentiation. Reprod Toxicol. 9(3):245-55.60Hatzopoulos et al. 1998, Isolation and characterization of endothelial progenitor cells from mouse embryos.Development. 125(8):1457-68.61Himori, et al , 1984, Chemotherapeutic susceptibility of human bone marrow progenitor cells and human myelogenous leukemia cells (HL-60) in co-culture: preliminary report. Int J Cell Cloning. 2(4):254-62.62Hirashima et al. 1999, Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis. Blood. 93(4):1253-63.63Hsieh et al. "Effects of glucose on placental hormones in the human term placenta in vitro" J. Formos. Med. Assoc. 96:309-313 (1997).64Hume et al., "Red Blood Cell Transfusions For Preterm Infants: The Role of Evidence-Based Medicine," Seminars in Perinatology, W.B. Saunders, GB 21(1):14-15 (1997).65Jaroscak et al. "Preliminary characterization of the surface staining of placental derived adherent cells: a potential new source of stroma for umbilical cord blood (UCB) expansion," Blood 96(11, Pt 2) (2000).66Kawata et al., "Transcriptional Control of HLA-A,B,C Antigen in Human Placental Cytotrophoblast Isolated Using Trophoblast- and HLA-Specific Monoclonal Antibodies and the Fluorescence-Activated Cell Sorter," J. Exp. Med. 160(3):633-51 (1984).67Keown et al., 1990, Methods for introducing DNA into mammalian cells. Methods Enzymol. 185:527-37.68Korbling et al., 2002, Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med. 346(10):738-46.69Kozbor et al., 1983, The productrion of monoclonal antibodies from human lymphocytes. Immunology Today 4, 72-79.70Kurtzberg et al., 1996, Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 335:157-166.71Larsson et al., 2002, Angiogenesis. 5:107-110.72Leonard et al., 2003, Oncologist. 8:411-424.73Lowy et al. 1980, Isolation of transforming DNA: cloning the hamster aprt gene. Cell. 22(3):817-23.74Ma et al., 1999, Development of an in vitro human placenta model by the cultivation of human ytophoblasts in a fiber-based bioreactor system, tissue Engineering 5:91-102.75MacLaren et al., 1992, Inter- and Intraspecific Placentae in Sheep, Goats and Sheep-Goat Chimaeras, J Comp Pathol, 106:279-297.76Madri et al., 1983, Capillary endothelial cell cultures: phenotypic modulation by matrix components, J Cell Biol 97:153-165.77Malek et al. "Lack of transport of erythropoietin across the human placenta as studied by an in vitro perfusion system," European Journal of Physiology 427:157-161 (1994).78Marmont, "New Horizons in the Treatment of Autoimmune Diseases: Immunoablation and Stem Cell Transplantation," Ann. Rev. Medicine 51:115-134 (2000).79Melchner, et al., 1985, Human placental conditioned medium reverses apparent commitment to differentiation of human promyelocytic leukemia cells (HL60) Blood. 66(6):1469-72.80Minguell et al., Exp Biol Med 226:507-520 (2001).81Moore et al., 1997, "A simple perfusion technique for isolation of maternal intervillous blood mononuclear cells from human placentae," J. Immunol. Methods 209(1):93-104.82M�hlemann et al., 1995, Placenta. 16:367-373.83Mulligan and Berg, 1981 Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase Proc Natl Acad Sci U S A. 78(4):2072-6.84Myllynen, dissertation, University of Oulu, 2003.85Nadkami et al. 1984, Effect of retinoic acid on bone-marrow committed stem cells (CFU-c) from chronic myeloid leukemia patients. Tumori. 70(6):503-5.86Non Final Office Action dated Dec. 15, 2009 in U.S. Appl. No. 12/030,170.87Non Final Office Action dated Feb. 1, 2011 in U.S. Appl. No. 10/721,144.88Non Final Office Action dated Feb. 4, 2009 in U.S. Appl. No. 11/592,544.89Non Final Office Action dated Jul. 15, 2010 in U.S. Appl. No. 11/982,291.90Non Final Office Action dated Jul. 19, 2010 in U.S. Appl. No. 11/982,007.91Non Final Office Action dated Jul. 9, 2010 in U.S. Appl. No. 12/259,259.92Non Final Office Action dated Jun. 4, 2010 in U.S. Appl. No. 12/030,170.93Non Final Office Action dated Jun. 7, 2010 in U.S. Appl. No. 11/648,813.94Non Final Office Action dated Jun. 7, 2010 in U.S. Appl. No. 11/980,012.95Non Final Office Action dated May 24, 2010 in U.S. Appl. No. 11/982,211.96Non Final Office Action dated May 26, 2010 in U.S. Appl. No. 12/030,161.97Non-Final Office Action dated Oct. 21, 2009 in U.S. Appl. No. 11/648,804.98Notice of Allowance dated Aug. 12, 2009 in U.S. Appl. No. 11/187,400.99Notice of Allowance dated Jan. 10, 2011 in U.S. Appl. No. 11/648,813.100Notice of Allowance dated Nov. 29, 2010 in U.S. Appl. No. 11/980,012.101Notice of Allowance in U.S. Appl. No. 10/004,942, now US Patent No. 7,045,148, Sep. 15, 2005.102Notice of Allowance in U.S. Appl. No. 10/074,976, now US Patent No. 7,311,904, Aug. 15, 2007.103Notice of Allowance in U.S. Appl. No. 10/366,671, now US Patent No. 7,311,905, Sep. 10, 2007.104Notice of Allowance in U.S. Appl. No. 10/640,428, now US Patent No. 7,255,879, May 21, 2007.105Office Action dated Apr. 20, 2007 in U.S. Appl. No. 11/187,400.106Office Action dated Aug. 28, 2003 in U.S. Appl. No. 10/076,180.107Office Action dated Dec. 16, 2004 in U.S. Appl. No. 10/004,942, now US Patent No. 7,045,148.108Office Action dated Dec. 28, 2006 in U.S. Appl. No. 10/721,144.109Office Action dated Dec. 5, 2003 in U.S. Appl. No. 10/004,942, now US Patent No. 7,045,148.110Office Action dated Feb. 5, 2008 in U.S. Appl. No. 10/721,144.111Office Action dated Jan. 11, 2006 in U.S. Appl. No. 10/721,144.112Office Action dated Jan. 19, 2006 in U.S. Appl. No. 10/640,428, now US Patent No. 7,255,879.113Office Action dated Jan. 26, 2009 in U.S. Appl. No. 11/648,813.114Office Action dated Jan. 29, 2006 in U.S. Appl. No. 10/366,671, now US Patent No. 7,311,905.115Office Action dated Jan. 4, 2008 in U.S. Appl. No. 11/187,400.116Office Action dated Jan. 5, 2006 in U.S. Appl. No. 10/074,976, now US Patent No. 7,311,904.117Office Action dated Jun. 14, 2006 in U.S. Appl. No. 10/721,144.118Office Action dated Jun. 15, 2004 in U.S. Appl. No. 10/004,942, now US Patent No. 7,045,148.119Office Action dated Jun. 20, 2005 in U.S. Appl. No. 10/004,942, now US Patent No. 7,045,148.120Office Action dated Jun. 20, 2005 in U.S. Appl. No. 10/076,180.121Office Action dated Jun. 27, 2007 in U.S. Appl. No. 10/721,144.122Office Action dated Mar. 18, 2004 in U.S. Appl. No. 10/076,180.123Office Action dated Mar. 18, 2010 in U.S. Appl. No. 10/721,144.124Office Action dated Mar. 27 2007 in U.S. Appl. No. 10/074,976, now US Patent No. 7,311,904.125Office Action dated Mar. 29, 2005 in U.S. Appl. No. 10/779,369.126Office Action dated May 14, 2007 in U.S. Appl. No. 10/366,671, now US Patent No. 7,311,905.127Office Action dated May 22, 2008 in U.S. Appl. No. 11/187,400.128Office Action dated May 7, 2003 in U.S. Appl. No. 10/004,942, now US Patent No. 7,045,148.129Office Action dated Oct. 10, 2006 in U.S. Appl. No. 10/366,671, now US Patent No. 7,311,905.130Office Action dated Oct. 18, 2006 in U.S. Appl. No. 10/640,428, now US Patent No. 7,255,879.131Office Action dated Oct. 20, 2004 in U.S. Appl. No. 10/076,180.132Office Action dated Oct. 4, 2005 in U.S. Appl. No. 10/721,144.133Office Action dated Sep. 20, 2006 in U.S. Appl. No. 10/074,976, now US Patent No. 7,311,904.134Office Action dated Sep. 23, 2004 in U.S. Appl. No. 10/074,976, now US Patent No. 7,311,904.135O'Hare et al. 1981, Transformation of mouse fibroblasts to methotrexate resistance by a recombinant plasmid expressing a prokaryotic dihydrofolate reductase. Proc Natl Acad Sci U S A. 78(3):1527-31.136Oppenheim et al., 2001, Evidence against humoral immune attach as the cause of sheep-goat interspecies and hybrid pregnancy failure in the doe, Theriogenology 55:1567-1581.137Ordi et al., 1998, Am J Surg Pathol. 8:1006-1011.138Papaioannou et al., Stem Cells Handbook:19-31 (2004).139Parolini et al. "Concise review: Isolation and characterization of cells from human term placenta: Outcome of the first international workshop on placenta derived stem cells" Stem Cells 26:300-311 (2008).140Pittenger, M. F., et al. "Multilineage Potential of Adult Human Mesenchymal Stem Cells," Science (1999) U.S. vol. 284, No. 5411, pp. 143-147.141Placenta, Britannica Online, 2003.142Ponticiello et al. "Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy" Journal of Biomedical Materials Research 52:246-255 (2000).143Ray et al., 1997, CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family. J Biol Chem. Jul. 25, 1997;272(30):18702-8.144Reubinoff, "Neural Progenitors from Human Embryonic Stem Cells," Nature Biotech. 19(12):1134-1140 (2001).145Reyes et al. 2002, Origin of endothelial progenitors in human postnatal bone marrow.J Clin Invest. 109(3):337-46.146Reyes et al., "Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells," Blood 98(9):2615-2625 (2001).147Santerre et al., 1984, Expression of prokaryotic genes for hygromycin B and G418 resistance as dominant-selection markers in mouse L cells. Gene. 30(1-3):147-56.148Semenov et al. "Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of sternness after isolation" American Journal of Obstetrics & Gynecolocy 202:193.e1-13 (2010).149Shamblott, et al., 1998, Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci U S A. 95(23):13726-31.150Slager 1993, Transforming growth factor-beta in the early mouse embryo: implications for the regulation of muscle formation and implantation. Dev Genet. 14(3):212-24.151Smithies et al. 1985, Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature. 317(6034):230-4.152Srour, 1999, Ex vivo expansion of hematopoietic stem and progenitor cells. Are we there yet? The Journal of Hematotherapy 8:93-102.153Stromberg et al., 1980, Methods in cell biology, Chapter 10: The human Placenta in cell and organ culture, 21:227-252.154Szybalska and Szybalska, 1962, Genetics of human cell lines IV: DNA-mediated heritable transformation of biochemical trait. PNAS 48: 2026-2034.155Thomas and Capecchi, 1987, Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell. 51(3):503-12.156Thomson et al., 1998, Embryonic stem cell lines derived from human blastocysts. Science. 282 (5391): 1145-7.157Totipotent Stem Cells, Medline, Mesh Database, 2004.158Totipotent Stem Cells, Stem Cells Information Center Online, 2004.159Tremblay et al., 2001, Diethylstilbestrol regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERR beta. Genes Dev. 15(7):833-8.160Turner et al., 1992, "A modified harvest technique for cord blood hematopoietic stem cells," Bone Marrow Transplantation 10:89-91.161U.S. Appl. No. 11/580,588, filed Oct. 13, 2006, Paludan.162U.S. Appl. No. 11/580,625, filed Oct. 13, 2006, Heidaran.163U.S. Appl. No. 11/648,802, filed Dec. 28, 2006, Heidaran.164U.S. Appl. No. 11/648,804, filed Dec. 28, 2006, Edinger.165U.S. Appl. No. 11/648,812, filed Dec. 28, 2006, Heidaran.166U.S. Appl. No. 11/648,813, filed Dec. 28, 2006, Edinger.167U.S. Appl. No. 11/648,824, filed Dec. 28, 2006, Heidaran.168U.S. Appl. No. 11/877,475, filed Oct. 23, 2007, Edinger et al.169U.S. Appl. No. 11/982,211, filed Oct. 31, 2007, Heidaran et al.170U.S. Appl. No. 11/982,291, filed Oct. 31, 2007, Edinger et al.171U.S. Appl. No. 12/030,161, filed Feb. 12, 2008, Edinger et al.172U.S. Appl. No. 12/030,170, filed Feb. 12, 2008, Edinger et al.173U.S. Appl. No. 12/823,063, filed Jun. 24, 2010, Hariri.174U.S. Appl. No. 12/829,326, filed Jul. 1, 2010, Abbot.175U.S. Appl. No. 12/846,765, filed Jul. 29, 2010, Edinger et al.176U.S. Appl. No. 12/848,007, filed Jul. 30, 2010, Edinger et al.177U.S. Appl. No. 13/081,415, filed Apr. 6, 2011, Abbot.178U.S. Appl. No. 13/081,422, filed Apr. 6, 2011, Edinger.179Uchimura et al. 1998, Human N-acetylglucosamine-6-O-sulfotransferase involved in the biosynthesis of 6-sulfo sislyl Lewis X: molecular cloning, chromosomal mapping, and expression in various organs and tumor cells. J Biochem (Tokyo). 124(3):670-8.180Van Bekkum, Verh Disch Ges Patol 74:19-24 (1990).181Vawda et al., "Stem Cell Therapies for Perinatal Brain Injuries", Seminars in Fetal and Neonatal Medicine, Elsevier, GB 12(4):259-272 (2007).182Viscord, 2001, Umbilical cord blood can save lives (Informational brochure), Boston: ViaCell CENTR-BRO R1 Oct. 2001.183Wang et al., 2001, "Enhanced recovery of hematopoietic progenitor and stem cells from cultivated, postpartum human placenta," Blood 98(11/1):183a Abstract No. 769.184Wigler et al. 1997, Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell. 11(1):223-32.185Woods et al., "Osomometric and permeability characteristics of human placental/umbilical cord blood CD34+ cells and their application to cryopreservation," J. Hematother. Stem Cell Res. 9(2):161-173 (2000).186Xu et al. "Feeder-free growth of undifferentiated human embryonic stem cells" Nature Biotechnology 19:971-974 (2001).187Yan et al., 2001, Retinoic acid promotes differentiation of trophoblast stem cells to a giant cell fate.Dev Biol. 235(2):422-32.188Ye et al., 2001, "Recovery of placental-derived adherent cells with mesenchymal stem cell characteristics," Blood 98(11/1):147b Abstract No. 4260.189Yen et al. "Isolation of multipotent cells from human term placenta" Stem Cells 23:3-9 (2005).190Yin et al "AC133, a novel marker for human hematopoietic stem and progenitor cells" Blood 90(12):5002-5012 (1997).191Zhao, et al., "Human Bone Marrow Stem Cells Exhibit Neural Phenotypes After Transplantation and Ameliorate Neurological Deficits with Ischemic Brain Injury in Rats," Abstract of the Annual Meeting of the Society for Neuroscience, Society of Neuroscience, Washington, DC, 26(Jan. 2002):860.01, XP001159670 (2000).192Zhao, et al., "Transplanted Human Bone Marrow-Derived Adult Stem Cells Survive and Improve Functional Outcome in a Rat Model of Cortical Ischemic Brain Injury," Experimental , Neurology, Academic Press, New York, 164(2):465-466, XP001159669 (2000).* Cited by examinerReferenced byCiting PatentFiling datePublication dateApplicantTitleUS8071376Oct 13, 2006Dec 6, 2011Anthrogenesis CorporationProduction of oligodendrocytes from placenta-derived stem cellsUS8372437Aug 17, 2007Feb 12, 2013Mimedx Group, Inc.Placental tissue graftsUS8435788Jun 24, 2010May 7, 2013Anthrogenesis CorporationTissue matrices comprising placental stem cellsUS8460715Aug 7, 2012Jun 11, 2013Mimedx Group, Inc.Placental tissue graftsUS8460716Aug 7, 2012Jun 11, 2013Mimedx Group, Inc.Method for applying a label to a placental tissue graftUS8597687Aug 7, 2012Dec 3, 2013Mimedx Group, Inc.Methods for determining the orientation of a tissue graftUS8623421Jul 26, 2013Jan 7, 2014Mimedx Group, Inc.Placental graftUS20100047351 *Aug 20, 2009Feb 25, 2010Andy ZeitlinTreatment of stroke using isolated placental cellsUS20110223141 *May 16, 2011Sep 15, 2011Anthrogenesis CorporationTreatment of brain or spinal cord injury using placental stem cells* Cited by examinerClassifications U.S. Classification424/93.1, 435/325, 435/366International ClassificationA61P29/00, C12M1/34, C12N5/00, A61K35/44, A61K48/00, A61M1/02, A61P9/00, C12N5/02, A61P17/02, C12N5/0789, A61K35/28, C12N15/09, A61P7/06, A61P25/28, A61P3/00, C12N5/073, C12M3/00, A61K35/14, A61P25/00, A61P27/02, A01N63/00, A61P27/06, C12M1/36, A61K35/50, A61P25/16, A61P5/14, A61P21/00, A61P9/10, A61K35/12, C12N5/0775, A61P13/12, A61P43/00, C12M1/00, C12N15/00Cooperative ClassificationC12N5/0668, A61M2210/1466, C12N5/0605, C12N2510/02, A61K35/12, A61M2210/1458, C12N2533/90, A61M2202/0462, A61K48/00, C12N2509/00, A61M1/02European ClassificationC12N5/06B21P, A61M1/02, C12N5/06B11P, C12N5/00S, C12N5/06B2LLegal EventsDateCodeEventDescriptionJul 2, 2010ASAssignmentFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HARIRI, ROBERT J.;REEL/FRAME:24634/33Owner name: ANTHROGENESIS CORPORATION,NEW JERSEYEffective date: 20020218Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HARIRI, ROBERT J.;REEL/FRAME:024634/0033Owner name: ANTHROGENESIS CORPORATION, NEW JERSEYRotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services©2012 Google